Thats why we combed Reddit to find out what people are currently talking about in obesity and GLP-1 communities and asked the following medical experts to respond to readers most pressing questions: Kia Mitchell, MD Double board-certified family and obesity medicine physician and founder of the International Womens Obesity Network Marsha Novick, MD, FAAFP Spokesperson for The Obesity Society and board member of the American Board of Obesity Medicine Richele Corrado, DO, MPH Spokesperson for The Obesity Society and medical director, internist, and obesity medicine physician at Revolution Medicine, Health & Fitness Sherrie Singh-Bryan, PharmD, CDCES Clinical pharmacist and certified diabetic care and education specialist at Winn Army Community Hospital in Fort Stewart, Georgia Editors note: These interviews have been edited for length and clarity
Targeted therapy The ferroptosis pathway can be broadly divided into GPX4-dependent and GPX4-independent pathways
Notably, the anti-ferroptotic activity of FSP1 does not alter glutathione levels, indicating a GPX4-independent mechanism
its basic receptor biology
So easy to do and effective
This atomic arrangement also permits glutathione to bond to other cysteine-containing proteins, which allows it to regulate multiple processes, including metabolic pathways, calcium balance, cellular remodeling, and protein folding
